Effect of poly(/V-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles

Biomacromolecules

Volumn 10, Issue 2, 2009, Pages 408-416

  Gaucher, Geneviéve ^a   Asahina, Kinji ^b   Wang, Jiaohong ^b,c   Leroux, Jean Christophe ^a,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEINS; BIODEGRADABLE NANOPARTICLES; CIRCULATION TIME; COATED NANOPARTICLES; COATED PARTICLES; COATING AGENTS; COATING POLYMERS; COMPLEMENT SYSTEMS; ENHANCED UPTAKES; IN-VITRO; IN-VIVO; KUPFFER CELLS; POLY (D ,L-LACTIDE) (DLLA); POLY(ETHYLENE GLYCOL); PREFERENTIAL ADSORPTIONS; PROTEIN ADSORPTIONS; PROTEIN SOLUTIONS;

ADSORPTION; ANTIGEN-ANTIBODY REACTIONS; BODY FLUIDS; ETHYLENE; ETHYLENE GLYCOL; MACROPHAGES; NANOPARTICLES; PHARMACOKINETICS; POLYETHYLENE OXIDES; VANADIUM;

POLYETHYLENE GLYCOLS;

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; APOLIPOPROTEIN; BOVINE SERUM ALBUMIN; COMPLEMENT; COPOLYMER; IMMUNOGLOBULIN G; NANOPARTICLE; POLY(N VINYLPYRROLIDONE) BLOCK POLY(LACTIDE); POLYLACTIDE; POVIDONE DERIVATIVE; UNCLASSIFIED DRUG; BIOMATERIAL; MACROGOL DERIVATIVE; POLY(N VINYL PYRROLIDONE) BLOCK POLY(D,L LACTIDE); POLY(N-VINYL-PYRROLIDONE)-BLOCK-POLY(D,L-LACTIDE); POLYSTYRENE DERIVATIVE; POLYVINYL DERIVATIVE; PROTEIN;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DRUG DISTRIBUTION; KUPFFER CELL; MACROPHAGE; MALE; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SERUM; ANIMAL; CHEMISTRY; COMPLEMENT ACTIVATION; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PHARMACOKINETICS;

MURINAE; RATTUS;

ADSORPTION; ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; COMPLEMENT ACTIVATION; KUPFFER CELLS; MACROPHAGES; MICE; NANOPARTICLES; PHAGOCYTOSIS; PHARMACOKINETICS; POLYETHYLENE GLYCOLS; POLYSTYRENES; POLYVINYLS; PROTEINS; RATS;

EID: 64149086416     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm801178f     Document Type: Article

References (49)

1. Gref, R.; Minamitake, Y.; Peracchia, M. T.; Trubetskoy, V.; Torchilin. V.; Langer, R. Science 1994, 263, 1600-1603.
2. Dunn, S. E.; Brindley, A.; Davis, S. S.; Davies, M. C.; Illum, L. Pharm. Res. 1994, 11, 1016-1022.
3. Fang, C.; Shi, B.; Pei, Y. Y.; Hong, M. H.; Wu, J.; Chen, H. Z. Eur. J. Pharm. Sci. 2006, 27, 27-36.
4. Moghimi, S. M.; Pavey, K. D.; Hunter, A. C. FEBS Lett. 2003, 547, 177-182.
5. Furtado Mosqueira, V. C.; Legrand, P.; Morgat, J.-L.; Vert, M.; Mysiakine, E.; Gref, R.; Devissaguet, J.-P.; Barratt, G. Pharm. Res. 2001, 18, 1411-1419.
6. Owens, D. E., III.; Peppas, N. A. Int. J. Pharm. 2006, 307, 93-102.
7. Beletsi, A.; Panagi, Z.; Avgoustakis, K. Int. J. Pharm. 2005, 298, 233-241.
8. Vonarbourg, A.; Passirani, C.; Saulnier, P.; Benoit, J.-P. Biomaterials 2006, 27, 4356-4373.
9. Stolnik, S.; Daudali, B.; Arien, A.; Whetstone, J.; Heald, C. R.; Garnett, M. C.; Davis, S. S.; Illum, L. Biochim. Biophys. Acta 2001, 1514, 261-279.
10. Gref, R.; Luck, M.; Quellec, P.; Marchand, M.; Dellacherie, E.; Harnisch, S.; Blunck, T.; Muller, R. H. Colloids Surf., B 2000, 18, 301-313.
11. Peracchia, M. T.; Harnisch, S.; Pinto-Alphandary, H.; Gulik, A.; Dedieu, J. C.; Desmaele, D.; d'Angelo, J.; Muller, R. H.; Couvreur, P. Biomaterials 1999, 20, 1269-1275.
12. Lemarchand, C.; Gref, R.; Couvreur, P. Eur. J. Pharm. Biopharm. 2004, 58, 327-41.
13. Le Ray, A. M.; Vert, M.; Gautier, J C.; Benoit,J.P. Int. J. Pharm. 1994, 106, 201-211.
14. Torchilin, V. P.; Levchenko, T. S.; Whiteman, K. R.; Yaroslavov, A. A.; Tsatsakis, A. M.; Rizos, A. K.; Michailova, E. V.; Shtilman, M. I. Biomaterials 2001, 22, 3035-44.
15. Doebbler, G. F. Cryobiology 1966, 3, 2-11.
16. Deluca, P. P.; Townsend, M. W. J. Parenter. Sci. Technol. 1988, 42, 190-199.
17. Hayama, M.; Yamamoto, K.; Kohori, F.; Uesaka, T.; Ueno, Y.; Sugaya, H.; Itagaki, I.; Sakai, K. Biomaterials 2004, 25, 1019-28.
18. Ward, R. A.; Klein, E.; Harding, G. B.; Murchison, K. E. ASAIO Trans. 1988, 34, 334-7.
19. Torchilin, V. P.; Shtilman, M. I.; Trubetskoy, V. S.; Whiteman, K.; Milstein, A. M. Biochim. Biophys. Acta 1994, 1195, 181-4.
20. Benahmed, A.; Ranger, M.; Leroux, J. C. Pharm. Res. 2001,18, 323-28.
21. Luo, L.; Ranger, M.; Lessard, D. G.; Le Garrec, D.; Gori, S.; Leroux, J. C.; Rimmer, S.; Smith, D. Macromolecules 2004, 37, 4008-4013.
22. Le Garrec, D.; Gori, S.; Luo, L.; Lessard, D.; Smith, D. C.; Yessine, M. A.; Ranger, M.; Leroux, J. C. J. Controlled Release 2004, 99, 3-101.
23. Le Garrec, D.; Gori, S.; Karkan, D.; Luo, L.; Lessard, D.; Smith, D.; Ranger, M.; Yessine, M. A.; Leroux, J. C. J.Dnug Delivery Sci Tech 2005, 15, 115-120.
24. Gaucher, G.; Poreba, M.; Ravenelle, F.; Leroux, J. C. J. Pharm. Sci. 2007, 96, 1763-75.
25. Vila, A.; Gill, H.; McCallion, O.; Alonso, M. J. J. Controlled Release 2004, 98, 231-244.
26. Verrecchia, T.; Huve, P.; Bazile, D.; Veillard, M.; Spenlehauer, G.; Couvreur, P. J. Biomed. Mater. Res. 1993, 27, 1019-1028.
27. Chen, L.; Xiong, S.; She, H.; Lin, S. W.; Wang, J.; Tsukamoto, H. J. Biol. Chem. 2007, 282, 5582-8.
28. Absolom, D. R. Methods Enzymol. 1986, 132, 281-318.
29. Reichner, J. S.; Fitzpatrick, P. A.; Wakshull, E.; Albina, J. E. Immunology 2001, 104, 198-206.
30. Allemann, E.; Gravel, P.; Leroux, J. C.; Gurny, C.; Balan, R. J. Biomed. Mater. Res. 1997, 37, 229-234.
31. Johnson, A. M.; Rohlfs, E. M.; Silverman, L. M. In Tietz fundamentals of clinical chemistry; Burtis, C. A., Ashwood, E. R., Eds.; W.B. Saunders: Toronto, 2001; pp 325-351.
32. Ogawara, K.; Furumoto, K.; Nagayama, S.; Minato, K.; Higaki, K.; Kai, T.; Kimura, T. J. Controlled Release 2004, 100, 451-5.
33. Hsu, M. J.; Juliano, R. L. Biochim. Biophys. Acta 1982, 720, 411-9.
34. Patel, H. M. Crit. Rev. Ther. Drug Carrier Syst. 1992, 9, 39-90.
35. Thiele, L.; Diederichs, J. E.; Reszka, R.; Merkle, H. P.; Walter, E. Biomaterials 2003, 24, 1409-18.
36. Roser, M.; Fischer, D.; Kissel, T. Eur. J. Pharm. Biopharm. 1998, 46, 255-63.
37. Allen, C.; Dos Santos, N.; Gallagher, R.; Chiu, G. N. C.; Shu, Y.; Li, W. M.; Johnstone, S. A.; Janoff, A. S.; Mayer, L. D.; Webb, M. S.; Bally, M. B. Biosci. Rep. 2002, 22, 225-250.
38. De Souza Delgado, A.; Leonard, M.; Dellacherie, E. Langmuir 2001, 17, 4386-4391.
39. Zahr, A. S.; Davis, C. A.; Pishko, M. V. Langmuir 2006, 22, 8178-8185.
40. Mosqueira, V. C.; Legrand, P.; Gulik, A.; Bourdon, O.; Gref, R.; Labarre, D.; Barratt, G. Biomaterials 2001, 22, 2967-79.
41. Leroux, J. C.; Gravel, P.; Balant, L.; Volet, B.; Anner, B. M.; Alleman, E.; Doelker, E.; Gurny, R. J. Biomed. Mater. Res. 1994, 28, 471-481.
42. Leroux, J. C.; De Jaeghere, F.; Anner, B.; Doelker, E.; Gurny, R. Life Sci. 1995, 57, 695-703.
43. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Pharmacol. Rev. 2001, 53, 283-318.
44. Muller, R. H.; Goppert, T. M. In Pole oflipid excipients in modifying oral and parenteral drug delivery; Wasan, K., Ed.; Wiley and Sons, Inc.: New York, 2007.
45. Torchilin, J. Liposome Res. 1994, 4, 725-739.
46. Panagi, Z.; Beletsi, A.; Evangelatos, G.; Livaniou, E.; Ithakissios, D. S.; Avgoustakis, K. Int. J. Pharm. 2001, 221, 143-152.
47. Torchilin, V. P.; Trubetskoy, V. S. Adv. Drug Delivery Rev. 1995, 16, 141-155.
48. Lee, J. H.; Lee, H. B.; Andrade, J. D. Prog. Polym. Sci. 1995, 20, 1043-1079.
49. Kan, C.; Cai, W.; Li, C.; Zhang, L. J. Mater. Res. 2005, 20, 320-324.